• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 3
      Alopecia Areata–Specific Patient-Reported Outcome Measures - 10 hour(s) ago

      This systematic review aims to identify and critically appraise the quality of the measurement properties of existing alopecia areata–specific patient-reported outcome measures and to provide evidence-based recommendations on the most valid patient-reported outcome measures.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Systematic review: There is still an unmet need for high-quality validation studies on the internal structure of alopecia areata–specific patient-reported outcome measures. https://t.co/DZLY2nB5Le https://t.co/YjYssh08Ja

    • Mashup Score: 9
      Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body - 1 day(s) ago

      This randomized clinical trial assesses the safety and efficacy of roflumilast foam, 0.3%, in patients with psoriasis of the scalp and body.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Most viewed this week from @JAMADerm: Roflumilast foam 0.3% improved psoriasis symptoms on the scalp and body with low rates of adverse events in patients aged 12 and older. https://t.co/BII7xvGF9V https://t.co/cquMSJuF3R

    • Mashup Score: 3
      DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis - 1 day(s) ago

      This study assesses the psychometric properties of a 7-item dermatology-specific treatment satisfaction instrument (DermSat-7) among patients with psoriasis.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        DermSat-7 is a valid and reliable instrument for measuring treatment satisfaction in patients with psoriasis in clinical trials and clinical practice. https://t.co/nDQyo91GT4

    • Mashup Score: 11
      Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris - 2 day(s) ago

      This cohort study examines the safety and efficacy of rituximab for patients with pempigus foliaceus.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Rituximab is effective and safe for treating pemphigus foliaceus (PF) and pemphigus vulgaris (PV), with PF patients showing lower relapse rates and higher sustained remission compared to PV patients. https://t.co/Q9vm1DSKok

    • Mashup Score: 8
      The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products - 3 day(s) ago

      This quality improvement study examines the effects of formulation on benzene levels detected in over-the-counter benzoyl peroxide products.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Benzene levels in benzoyl peroxide acne treatments vary between products and brands, largely due to formulation characteristics. https://t.co/bDxcTX95Jb

    • Mashup Score: 17
      Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body - 3 day(s) ago

      This randomized clinical trial assesses the safety and efficacy of roflumilast foam, 0.3%, in patients with psoriasis of the scalp and body.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Most viewed this week from @JAMADerm: Roflumilast foam 0.3% improved psoriasis symptoms on the scalp and body with low rates of adverse events in patients aged 12 and older. https://t.co/LEXIlyMD7j https://t.co/wK16O43aRc

    • Mashup Score: 2
      Characteristics and Treatment of Multiple Adult Cutaneous Xanthogranuloma - 5 day(s) ago

      This case series describes the characteristics of cutaneous xanthogranuloma among a group of adult patients in France and explores the response profiles of several treatment options.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        In a case series of 29 patients, Multiple Adult Xanthogranuloma (MAXG) was found to be driven by activation of the MAPK pathway via somatic mutations. https://t.co/zVYT1mZ5Qd

    • Mashup Score: 6
      Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses - 6 day(s) ago

      This cross-sectional study evaluates the of neighborhood socioeconomic status with new hidradenitis suppurativa diagnoses within a single health system.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Lower neighborhood socioeconomic status was independently associated with higher odds of a new hidradenitis suppurativa diagnosis among dermatology patients. https://t.co/f63KnQ959f

    • Mashup Score: 8
      Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa - 7 day(s) ago

      This cross-sectional study examines the association between serum immunoglobulin G levels and underlying nicastrin variation in individuals with hidradenitis suppurativa.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        Elevated serum immunoglobulin G (IgG) levels can serve as a potential predictive biomarker for identifying individuals with hidradenitis suppurativa who carry a specific NCSTN variant. https://t.co/P12SvqKo8y

    • Mashup Score: 16
      Artificial Intelligence–Enabled Wearable Devices and Nocturnal Scratching in Mild Atopic Dermatitis - 8 day(s) ago

      This cohort study evaluates the accuracy and efficacy of an artificial intelligence–enabled wearable sensor with closed-loop haptic feedback to decrease nocturnal scratch in patients with mild atopic dermatitis who report a moderate to severe degree of scratching.

      Source: jamanetwork.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	JAMADerm
        JAMADerm

        An #AI-enabled wearable sensor with closed-loop haptic feedback may be used as a nonpharmacological intervention to reduce nocturnal scratching in patients with mild atopic dermatitis. https://t.co/dAXtpvZsZ6

    Load More

    JAMA Dermatology

    @JAMADerm

    JAMA #Dermatology publishes information concerning the skin, its diseases, and their treatment. #skincare

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings